Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.10.2 (
focal adhesion kinase
)
44,029
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The Discoidin, CUB, and LCCL domain-containing protein (DCBLD) family consists of two type-I transmembrane scaffolding receptors,
DCBLD1
and DCBLD2, which play important roles in development and cancer. The nonreceptor tyrosine kinases
FYN
and
ABL
are known to drive phosphorylation of tyrosine residues in YXXP motifs within the intracellular domains of DCBLD family members, which leads to the recruitment of the Src homology 2 (SH2) domain of the adaptors CT10 regulator of kinase (CRK) and CRK-like (CRKL). We previously characterized the
FYN
- and
ABL
-driven phosphorylation of DCBLD family YXXP motifs. However, we have identified additional
FYN
- and
ABL
-dependent phosphorylation sites on
DCBLD1
and DCBLD2. This suggests that beyond CRK and CRKL, additional DCBLD interactors may be regulated by
FYN
and
ABL
activity. Here, we report a quantitative proteomics approach in which we map the
FYN
- and
ABL
-regulated interactomes of DCBLD family members. We found
FYN
and
ABL
regulated the binding of several signaling molecules to
DCBLD1
and DCBLD2, including members of the 14-3-3 family of adaptors. Biochemical investigation of the DCBLD2/14-3-3 interaction revealed
ABL
-induced binding of 14-3-3 family members directly to DCBLD2.
...
PMID:FYN and ABL Regulate the Interaction Networks of the DCBLD Receptor Family. 3260 17